This is a prospective single-arm interventional study evaluating Therapeutic efficacy of a
combination of two pharmaceutical drugs, Azithromycin (AZIT) and Ivermectin (IVER)
administered orally in the treatment of head lice infestations. In case of persistence of
lice and / or nits on day 7, a second oral administration of combination Azithromycin +
Ivermectin will be considered.
The duration of the study period is 4 months, ie 1 month and ½ of inclusion and 2 months and
½ feedback. There will be a site initiation visit "site initiation visit" before inclusions
at D-7, two monitoring visits and a closing visit "close out visit" at the end of the
follow-up at 4 months.